José Antonio García Erce Highlights the Updating of the Criteria for the Donation of Plasmapheresis for Industrial Fractionation
José Antonio García Erce, Director of the Donation Center, Navarre Health Service (Osasunbidea), posted on LinkedIn:
“NEW CAT 2025 STANDARDS VERSION
As of YESTERDAY, December 19, the 6th edition of the CAT Standards in Hemotherapy 2025 comes into force. From now on, transfusion centres and services will have a period of three months to adopt the changes.
We must congratulate and thank all the professionals involved in the new version. There are interesting new developments.
I would like to highlight the updating of the criteria for the donation of plasmapheresis for industrial fractionation. It can be of great help to Transfusion Centers.
But I want to highlight a point that was already in the previous edition and that should also be applicable to transfusion centers, to Primary Care, as well as to all hospitals where transfusions are made:
4.2.7. TS must promote and participate in hospital Patient Blood Management (PBM) programs, including specific training.
Unfortunately, its definition included in the document, sorry, is not correct: “Patient Blood Management: a comprehensive and multidisciplinary strategy focused primarily on minimizing the use of allogeneic blood components, optimizing patient care by treating anemia, minimizing blood loss and bleeding, and improving their physiological reserve of red blood cells.” It does not focus on minimizing use, but on clinical improvement and patient safety, and preserving, promoting, and protecting the blood health of the entire population.”
Title: Patient blood management: haematology faces an urgent challenge in personalised medicine | Gestión de la sangre del paciente: la hematología ante un reto inaplazable en la medicina personalizada (original)
Authors: José Antonio García Erce

Read full paper here or have printable variant.
Read more from José Antonio García Erce on Hemostasis Today.
-
Oct 15, 2026, 17:08Babu Mia։ Targeting PPM1D to Eliminate Malignant Stem Cells in Myeloproliferative Neoplasms
-
Oct 15, 2026, 16:26Hauke Horstmann: Can an Existing Drug Be Repurposed to Treat Atherosclerosis?
-
Oct 15, 2026, 15:19Bernadette Borrelli: AdventHealth Teams Unite to Mark World Thrombosis Day
-
Oct 15, 2026, 15:03Mohamed Magdy: The Hematological Consequences of Portal Hypertension in Banti Syndrome
-
Oct 15, 2026, 14:34Marium Khan: New Systematic Review Examines Asundexian Safety and Efficacy in Cardiovascular Disease
-
Oct 15, 2026, 14:03JTH Research Recap Explores Occult Malignancy Screening in DVT
-
Oct 15, 2026, 13:52Thierry Peyrard: A Heartfelt Thank You Ahead of Blood 2026
-
Oct 15, 2026, 12:40Todd Keitz: DVT and PE Explained in Five Minutes
-
Oct 15, 2026, 12:35Bartosz Hudzik: Balancing Ischemic and Bleeding Risk After ACS and PCI